Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Volastra Therapeutics, Inc., explained in plain language.
This study aims to find the best dose of a new oral drug called sovilnesib for people with advanced ovarian cancer that has stopped responding to standard platinum-based chemotherapy. About 120 participants will take different doses to see which one is safest and shows the most p…
Phase: PHASE1 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC